Evidence map›Paper›PMID 42867817›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

3D Bioprinting Engineered Vascularized Skeletal Muscle Tissue.

Anna Tsukerman, Eliana O Fischer, Shulamit Levenberg

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna Tsukerman *Faculty of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel.
Eliana O Fischer *Faculty of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel.
Shulamit LevenbergFaculty of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel. shulamit@bm.technion.ac.il.ORCID https://orcid.org/0000-0001-5471-7339

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

3D bioprinting of vascularized tissues integrates additive manufacturing and tissue engineering to fabricate high-resolution, three-dimensional constructs. A key aspect of this method is embedding cells within a bioink, which provides structural support while encouraging cellular interaction during printing and subsequent cultivation. Commonly used bioinks are composed of extracellular matrix (ECM)-derived materials, mimicking the native tissue environment. Here, we describe a 3D bioprinting approach utilizing a collagen-fibrin bioink, termed ECM mix. This bioink formulation provides the mechanical strength required for skeletal muscle maturation while leveraging the proangiogenic properties of fibrin to support the formation of vascular networks. Printing is conducted at room temperature, and the constructs are incubated under physiological conditions to support tissue maturation.

Indexed as

BioprintingMuscle, SkeletalPrinting, Three-DimensionalTissue EngineeringAnimalsCollagenExtracellular MatrixFibrinHumansNeovascularization, PhysiologicTissue ScaffoldsCollagenFibrin3D bioprintingBioinksExtracellular matrixRegenerative medicineSkeletal muscle tissueTissue engineeringVascular network

Identifiers

PMID42867817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.